Paul Anthony Brennan

Paul Anthony Brennan discloses dealings in Eupraxia Pharmaceuticals Inc. to SEDI. The record holds 8 filings, for trades running from 1 November 2022 to 23 January 2026.

No open-market sale appears; the market trades are 4 purchases worth €89k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 1 option exercise.

The median purchase comes to €21k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 24 January 2026 came the latest disclosure, an option exercise for €35k in Eupraxia Pharmaceuticals Inc. The latest purchase dates back some time: it was published 335 days ago, on 26 November 2025. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.